Phase 4Not yet recruiting

Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

A Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety of Bupropion Hydrobromide in Adolescents and Children With Major Depressive Disorder

Sponsor
Bausch Health Americas, Inc. (Industry)
Enrollment
246 planned
Conditions
Major Depressive Disorder
Interventions
bupropion hydrobromide; Placebo
Ages
children
Registry
NCT02129751

Full record on ClinicalTrials.gov

From the registry

Double-Blind, Placebo-Controlled, Multicenter Study of Efficacy and Safety

Primary outcomes

  • Mean change from Baseline to EOT in total CDRS-R (raw) score

History

  1. Study completion expected

  2. Primary completion expected

  3. Expected to start

  4. Last registry update

  5. Registered